Persistence, Safety and Pharmacokinetics of Vedolizumab After Switching to the Subcutaneous Route in a Prospective French National Cohort Study.
BACKGROUND AND AIM We conducted a prospective study to evaluate the persistence, efficacy, pharmacokinetics, and safety of subcutaneous VDZ (SC-VDZ) after switching from the intravenous (IV) route. METHODS All patients with ulcerative colitis (UC) or Crohn's disease (CD) in clinical remission who switched from IV-VDZ...